175 related articles for article (PubMed ID: 38150606)
1. Systemic therapies for salivary gland carcinomas: an overview of published clinical trials.
Silva LC; Pérez-de-Oliveira ME; Pedroso CM; Leite AA; Santos-Silva AR; Lopes MA; Junior GD; Martins MD; Wagner VP; Kowalski LP; Squarize CH; Castilho RM
Med Oral Patol Oral Cir Bucal; 2024 Mar; 29(2):e280-e287. PubMed ID: 38150606
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Systemic therapies for salivary gland carcinoma (excluding adenoid cystic carcinoma): REFCOR recommendations by the formal consensus method.
Sarradin V; Digue L; Vergez S; Thariat J; Fakhry N; Chabrillac E; Bensadoun RJ; Ferrand FR; Even C
Eur Ann Otorhinolaryngol Head Neck Dis; 2023 Nov; ():. PubMed ID: 38040592
[TBL] [Abstract][Full Text] [Related]
4. Adenoid cystic carcinomas of the salivary gland, lacrimal gland, and breast are morphologically and genetically similar but have distinct microRNA expression profiles.
Andreasen S; Tan Q; Agander TK; Steiner P; Bjørndal K; Høgdall E; Larsen SR; Erentaite D; Olsen CH; Ulhøi BP; von Holstein SL; Wessel I; Heegaard S; Homøe P
Mod Pathol; 2018 Aug; 31(8):1211-1225. PubMed ID: 29467480
[TBL] [Abstract][Full Text] [Related]
5. Salivary gland carcinoma: Towards a more personalised approach.
Rached L; Saleh K; Casiraghi O; Even C
Cancer Treat Rev; 2024 Mar; 124():102697. PubMed ID: 38401478
[TBL] [Abstract][Full Text] [Related]
6. Systemic therapy in metastatic salivary gland carcinomas: A pathology-driven paradigm?
Alfieri S; Granata R; Bergamini C; Resteghini C; Bossi P; Licitra LF; Locati LD
Oral Oncol; 2017 Mar; 66():58-63. PubMed ID: 28249649
[TBL] [Abstract][Full Text] [Related]
7. A molecular guide to systemic therapy in salivary gland carcinoma.
Weaver AN; Lakritz S; Mandair D; Ulanja MB; Bowles DW
Head Neck; 2023 May; 45(5):1315-1326. PubMed ID: 36859797
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of p53 immunohistochemical expression in adenoid cystic carcinoma of the salivary glands: a meta-analysis.
Li Q; Huang P; Zheng C; Wang J; Ge M
Oncotarget; 2017 Apr; 8(17):29458-29473. PubMed ID: 28206977
[TBL] [Abstract][Full Text] [Related]
9. Salivary Gland Carcinoma: Novel Targets to Overcome Treatment Resistance in Advanced Disease.
Di Villeneuve L; Souza IL; Tolentino FDS; Ferrarotto R; Schvartsman G
Front Oncol; 2020; 10():580141. PubMed ID: 33194707
[TBL] [Abstract][Full Text] [Related]
10. Genomics in non-adenoid cystic group of salivary gland cancers: one or more druggable entities?
Cavalieri S; Platini F; Bergamini C; Resteghini C; Galbiati D; Bossi P; Perrone F; Tamborini E; Quattrone P; Licitra L; Locati LD; Alfieri S
Expert Opin Investig Drugs; 2019 May; 28(5):435-443. PubMed ID: 30897975
[TBL] [Abstract][Full Text] [Related]
11. Expression of cancer/testis antigens in salivary gland carcinomas with reference to MAGE-A and NY-ESO-1 expression in adenoid cystic carcinoma.
Beppu S; Ito Y; Fujii K; Saida K; Takino H; Masaki A; Murase T; Kusafuka K; Iida Y; Onitsuka T; Yatabe Y; Hanai N; Hasegawa Y; Ijichi K; Murakami S; Inagaki H
Histopathology; 2017 Aug; 71(2):305-315. PubMed ID: 28370175
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive genomic profiles of metastatic and relapsed salivary gland carcinomas are associated with tumor type and reveal new routes to targeted therapies.
Ross JS; Gay LM; Wang K; Vergilio JA; Suh J; Ramkissoon S; Somerset H; Johnson JM; Russell J; Ali S; Schrock AB; Fabrizio D; Frampton G; Miller V; Stephens PJ; Elvin JA; Bowles DW
Ann Oncol; 2017 Oct; 28(10):2539-2546. PubMed ID: 28961851
[TBL] [Abstract][Full Text] [Related]
13. A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact.
Locati LD; Perrone F; Cortelazzi B; Bergamini C; Bossi P; Civelli E; Morosi C; Lo Vullo S; Imbimbo M; Quattrone P; Dagrada GP; Granata R; Resteghini C; Mirabile A; Alfieri S; Orlandi E; Mariani L; Saibene G; Pilotti S; Licitra L
Eur J Cancer; 2016 Dec; 69():158-165. PubMed ID: 27821319
[TBL] [Abstract][Full Text] [Related]
14. A Single-Arm, Prospective, Phase II Study of Cisplatin Plus Weekly Docetaxel as First-Line Therapy in Patients with Metastatic or Recurrent Salivary Gland Cancer.
Kim HR; Lee SJ; Park S; Jung HA; Lee SH; Jeong HS; Chung MK; Ahn MJ
Cancer Res Treat; 2022 Jul; 54(3):719-727. PubMed ID: 34727492
[TBL] [Abstract][Full Text] [Related]
15. SOX10 Is a Sensitive Marker for Breast and Salivary Gland Adenoid Cystic Carcinoma: Immunohistochemical Characterization of Adenoid Cystic Carcinomas.
Yang C; Zhang L; Sanati S
Breast Cancer (Auckl); 2019; 13():1178223419842185. PubMed ID: 31105427
[TBL] [Abstract][Full Text] [Related]
16. Salivary gland-like tumors of the breast express basal-type immunohistochemical markers.
Reyes C; Jorda M; Gomez-Fernández C
Appl Immunohistochem Mol Morphol; 2013 Jul; 21(4):283-6. PubMed ID: 22935826
[TBL] [Abstract][Full Text] [Related]
17. MYB expression and translocation in adenoid cystic carcinomas and other salivary gland tumors with clinicopathologic correlation.
West RB; Kong C; Clarke N; Gilks T; Lipsick JS; Cao H; Kwok S; Montgomery KD; Varma S; Le QT
Am J Surg Pathol; 2011 Jan; 35(1):92-9. PubMed ID: 21164292
[TBL] [Abstract][Full Text] [Related]
18. Systemic therapy for salivary gland malignancy: current status and future perspectives.
Imamura Y; Kiyota N; Tahara M; Hanai N; Asakage T; Matsuura K; Ota I; Saito Y; Sano D; Kodaira T; Motegi A; Yasuda K; Takahashi S; Yokota T; Okano S; Tanaka K; Onoe T; Ariizumi Y; Homma A
Jpn J Clin Oncol; 2022 Apr; 52(4):293-302. PubMed ID: 35134985
[TBL] [Abstract][Full Text] [Related]
19. [Malignant epithelial salivary gland tumors. Clinical review of 2 decades].
Kokemüller H; Brüggemann N; Brachvogel P; Eckardt A
Mund Kiefer Gesichtschir; 2004 May; 8(3):191-201. PubMed ID: 15138857
[TBL] [Abstract][Full Text] [Related]
20. [MicroRNA-profiling in breast- and salivary gland-derived adenoid cystic carcinomas].
Kiss O; Tőkés AM; Spisák S; Szilágyi A; Lippai N; Szász AM; Kulka J
Orv Hetil; 2013 Jun; 154(25):963-8. PubMed ID: 23774803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
